Report Claims Success Treating Alzheimer's Memory Loss
Report Claims Success Treating Alzheimer's Memory Loss
By Amy Norton
HealthDay Reporter
MONDAY, Oct. 6, 2014 (HealthDay News) -- A researcher is reporting success in a small study of reversing memory problems associated with early stage Alzheimer's disease by using a complex program of lifestyle changes, supplements and hormones.
Of the first 10 patients treated, nine reported improvements in memory within three to six months, according to Dr. Dale Bredesen, a professor of neurology at the University of California, Los Angeles, who developed the program.
The full regimen involves 36 components, and is tailored to the individual, Bredesen said. In general, it involves diet changes such as eliminating simple carbohydrates and processed foods; regular exercise; stress reduction; good sleep habits; supplements like fish oil, curcumin and vitamin D; and, in some cases, hormone therapy.
Writing in the September issue of the journal Aging, Bredesen describes the cases of 10 patients undergoing the therapy -- half of whom were diagnosed with mild mental (cognitive) impairment or early-stage Alzheimer's.
The others had more-advanced Alzheimer's or "subjective" cognitive impairment -- where people have normal scores on tests of memory and thinking, but complain of problems in daily life.
The single patient who did not respond to the therapy had advanced Alzheimer's, Bredesen said. Alzheimer's, the most common form of dementia, is a progressive brain disease without a cure.
"Obviously, larger studies are warranted," Bredesen stressed. He said patients' daily lives had been altered. Several who'd had to quit their jobs were back at work, he noted.
Other experts called the findings "interesting," but urged caution.
"It's way too early to draw any conclusions from this," said Heather Snyder, director of medical and scientific operations for the Alzheimer's Association in Chicago. "It raises a lot of questions that should be explored in larger studies."
Dr. James Galvin, a professor of neurology at NYU Langone Medical Center in New York City, echoed that sentiment.
"I'm not knocking the concept," Galvin said. The factors the program targets -- including diet, physical activity and chronic body-wide inflammation -- are scientifically valid, he said.
But, Galvin added, it's hard to evaluate the specific therapies, particularly the supplements, based only on these case reports.
HealthDay Reporter
MONDAY, Oct. 6, 2014 (HealthDay News) -- A researcher is reporting success in a small study of reversing memory problems associated with early stage Alzheimer's disease by using a complex program of lifestyle changes, supplements and hormones.
Of the first 10 patients treated, nine reported improvements in memory within three to six months, according to Dr. Dale Bredesen, a professor of neurology at the University of California, Los Angeles, who developed the program.
The full regimen involves 36 components, and is tailored to the individual, Bredesen said. In general, it involves diet changes such as eliminating simple carbohydrates and processed foods; regular exercise; stress reduction; good sleep habits; supplements like fish oil, curcumin and vitamin D; and, in some cases, hormone therapy.
Writing in the September issue of the journal Aging, Bredesen describes the cases of 10 patients undergoing the therapy -- half of whom were diagnosed with mild mental (cognitive) impairment or early-stage Alzheimer's.
The others had more-advanced Alzheimer's or "subjective" cognitive impairment -- where people have normal scores on tests of memory and thinking, but complain of problems in daily life.
The single patient who did not respond to the therapy had advanced Alzheimer's, Bredesen said. Alzheimer's, the most common form of dementia, is a progressive brain disease without a cure.
"Obviously, larger studies are warranted," Bredesen stressed. He said patients' daily lives had been altered. Several who'd had to quit their jobs were back at work, he noted.
Other experts called the findings "interesting," but urged caution.
"It's way too early to draw any conclusions from this," said Heather Snyder, director of medical and scientific operations for the Alzheimer's Association in Chicago. "It raises a lot of questions that should be explored in larger studies."
Dr. James Galvin, a professor of neurology at NYU Langone Medical Center in New York City, echoed that sentiment.
"I'm not knocking the concept," Galvin said. The factors the program targets -- including diet, physical activity and chronic body-wide inflammation -- are scientifically valid, he said.
But, Galvin added, it's hard to evaluate the specific therapies, particularly the supplements, based only on these case reports.
Source...